VAPOTHERM INC

Delisted

CIK 1253176fmd_0E5X96X7BBMVKRT62JQ1SC2QJ3Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2018 to Jun 30, 2024, 26 periods

Income Statement · Annual · Millions · USD
Line item	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023
Total revenues	42	48	126	113	67	69
Cost of revenue	26	27	63	60	50	40
Gross profit	17	21	63	53	17	28
Research and development	9	13	17	18	21	14
Selling, general and administrative	45	56	89	92	74	52
Total operating expenses	54	69	106	110	118	67
Operating income	(37)	(48)	(43)	(57)	(100)	(39)
Interest expense	3	5	5	3	12	19
Interest and investment income	0	1	0	0	0	0
Other non-operating income (expense)	(5)	(3)	(8)	0	–	–
Income before taxes	(42)	(51)	(52)	(60)	(113)	(58)
Income tax expense	0	(0)	0	(0)	0	0
Net income from continuing operations	(42)	(51)	(52)	(60)	(113)	(58)
Net income	(42)	(51)	(52)	(60)	(113)	(58)
Net income to common shareholders	(43)	(51)	–	–	–	–